Jinhai Medical Technology Limited

SEHK:2225 Lagerbericht

Marktkapitalisierung: HK$7.9b

Jinhai Medical Technology Management

Management Kriterienprüfungen 3/4

We currently do not have sufficient information about the CEO.

Wichtige Informationen

Zhenfei Wang

Geschäftsführender

S$111.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts97.3%
Amtszeit als Geschäftsführer5.3yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements1.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.3yrs

Jüngste Management Updates

The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Jun 19
The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Recent updates

Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

Oct 06
Why We're Not Concerned About Jinhai Medical Technology Limited's (HKG:2225) Share Price

The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Jun 19
The CEO Of Jinhai Medical Technology Limited (HKG:2225) Might See A Pay Rise On The Horizon

Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

May 13
Investors Appear Satisfied With Jinhai Medical Technology Limited's (HKG:2225) Prospects As Shares Rocket 26%

Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

Mar 17
Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Jan 31
What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Jun 06
Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Mar 07
Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Zhenfei Wang im Vergleich zu den Einnahmen von Jinhai Medical Technology verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2024n/an/a

-S$10m

Mar 31 2024n/an/a

-S$7m

Dec 31 2023S$111kS$108k

-S$3m

Sep 30 2023n/an/a

-S$2m

Jun 30 2023n/an/a

S$6k

Mar 31 2023n/an/a

S$237k

Dec 31 2022S$240kS$237k

S$468k

Sep 30 2022n/an/a

S$443k

Jun 30 2022n/an/a

S$419k

Mar 31 2022n/an/a

S$86k

Dec 31 2021S$356kS$353k

-S$246k

Sep 30 2021n/an/a

S$320k

Jun 30 2021n/an/a

S$852k

Mar 31 2021n/an/a

S$1m

Dec 31 2020S$365kS$362k

S$1m

Sep 30 2020n/an/a

S$516k

Jun 30 2020n/an/a

-S$231k

Mar 31 2020n/an/a

-S$459k

Dec 31 2019S$362kS$161k

-S$686k

Vergütung im Vergleich zum Markt: Zhenfei's total compensation ($USD84.37K) is below average for companies of similar size in the Hong Kong market ($USD495.13K).

Entschädigung vs. Einkommen: Zhenfei's compensation has been consistent with company performance over the past year.

Geschäftsführer

Zhenfei Wang (43 yo)

5.3yrs

Amtszeit

S$111,000

Vergütung

Mr. Zhenfei Wang has been Chief Executive Officer and Executive Director of Jinhai Medical Technology Limited (formerly known as Jinhai International Group Holdings Limited) (formerly known as Kakiko Group...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Guobao Chen
Executive Chairman of the Board5.3yrsS$337.00k48.94%
HK$ 3.9b
Zhenfei Wang
CEO & Executive Director5.3yrsS$111.00kkeine Daten
Yunping Li
Executive Director1.3yrsS$86.00kkeine Daten
Man Yiu Wong
Chief Financial Officer5yrskeine Datenkeine Daten
Lei Liu
Chief Technical Officerless than a yearkeine Datenkeine Daten
Xiao He
Chief Marketing Officerless than a yearkeine Datenkeine Daten
Yuen Cheng
Company Secretaryless than a yearkeine Datenkeine Daten

1.3yrs

Durchschnittliche Betriebszugehörigkeit

50.5yo

Durchschnittliches Alter

Erfahrenes Management: 2225's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Guobao Chen
Executive Chairman of the Board5.3yrsS$337.00k48.94%
HK$ 3.9b
Zhenfei Wang
CEO & Executive Director5.3yrsS$111.00kkeine Daten
Yunping Li
Executive Director5.3yrsS$86.00kkeine Daten
Mingyang Yu
Non-Executive Director1.3yrsS$13.00kkeine Daten
Huasheng Wang
Non-Executive Director5.3yrsS$33.00kkeine Daten
Jianjun Yan
Independent Non-Executive Director5.3yrsS$21.00kkeine Daten
Yimin Fan
Independent Non-Executive Director5.3yrsS$21.00kkeine Daten
Meihua Yang
Independent Non-Executive Director2.8yrsS$21.00kkeine Daten

5.3yrs

Durchschnittliche Betriebszugehörigkeit

58.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 2225's board of directors are considered experienced (5.3 years average tenure).